BillionToOne Integrates Prenatal and Oncology Tests into Epic Aura Diagnostics Suite

BillionToOne has shared an update.

The company announced a collaboration with Epic Aura to integrate BillionToOne’s prenatal and oncology tests—UNITY Complete®, Northstar Select®, and Northstar Response®—into Epic’s Aura diagnostics suite. The integration is intended to streamline clinical workflows and expand access to advanced molecular diagnostics for prenatal and oncology care within Epic-enabled healthcare settings.

For investors, this collaboration could enhance BillionToOne’s market reach and test utilization by embedding its offerings directly into a widely used clinical software ecosystem. Integration with Epic’s infrastructure may lower adoption barriers for providers, potentially supporting higher test volumes and more stable recurring revenue over time. It also strengthens BillionToOne’s competitive position in the molecular diagnostics space by deepening its presence in both prenatal and oncology segments and aligning the company with a major health IT platform. The financial impact will depend on the pace of provider uptake, contracting terms with health systems, and any associated pricing or reimbursement dynamics, but the partnership is directionally positive for scaling commercialization and reinforcing the company’s position in clinical workflows.